Table 2

Estimated mortality and sample sizes for low, middle and high income countries and the mean number of cases per month per institution globally

ConditionMortality LIC
(%, n)
Mortality MIC
(%, n)
Mortality LMIC combined
(%, n)
Mortality HIC
(%, n)
Sample size for LICSample size for MICSample size for HICSample size for LMIC vs HIC (per group)Mean no. cases/ month/ institution (L, M and HIC combined)
OA ±TOF79.5%
(62/78)
41.8%
(623/1488)
43.7%
(685/1566)
2.7%
(6/221)
343423211.02
CDH47.4%
(130/274)
47.4%
(130/274)
20.4%
(201/982)
630.54
IA42.9%
(42/98)
40.0%
(97/241)
41.0%
(139/339)
2.9%
(12/407)
6014601425240.63
Gastroschisis83.1%
(211/254)
42.6%
(205/481)
56.6%
(416/735)
3.7%
(28/748)
292924150.85
Exomphalos25.5% (41/161)31.9% (132/414)30.1% (173/575)12.7% (40/316)104010401961150.63
ARM26.3%
(26/99)
17.5%
(243/1391)
18.1%
(269/1490)
3%
(14/462)
46046090851.34
Hirschsprung’s disease19.1% (33/173)16.8% (55/328)17.6%
(88/501)
2.3%
(43/1897)
5802580285792.21
  • ARM, anorectal malformation; CDH, congenital diaphragmatic hernia; HIC, high income countries; IA, intestinal atresia; LIC, low income countries; LMIC, low and middle income countries; MIC, middle income countries; OA, oesophageal atresia; TOF, tracheo-oesophageal fistula.